Cardiovascular pharmacology: An update

Henry Liu; Charles J. Fox; Shihai Zhang; Alan D. Kaye

doi:10.1016/j.anclin.2010.09.001

Cardiovascular pharmacology: An update

Henry Liu
, Charles J. Fox
, Shihai Zhang
, Alan D. Kaye

Department of Anesthesiology and Perioperative Medicine

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Some of these newer drugs are frequently used in the practice of cardiovascular anesthesiology. This article reviews the recent advances in cardiovascular medications related to the practice of cardiac anesthesia.

Original language	English (US)
Pages (from-to)	723-738
Number of pages	16
Journal	Anesthesiology Clinics
Volume	28
Issue number	4
DOIs	https://doi.org/10.1016/j.anclin.2010.09.001
State	Published - Dec 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Anesthesiology and Pain Medicine

Access to Document

10.1016/j.anclin.2010.09.001

Cite this

@article{ac6bc30fd6b64cb58c8bfdac3b95cb81,

title = "Cardiovascular pharmacology: An update",

abstract = "Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Some of these newer drugs are frequently used in the practice of cardiovascular anesthesiology. This article reviews the recent advances in cardiovascular medications related to the practice of cardiac anesthesia.",

author = "Henry Liu and Fox, \{Charles J.\} and Shihai Zhang and Kaye, \{Alan D.\}",

year = "2010",

month = dec,

doi = "10.1016/j.anclin.2010.09.001",

language = "English (US)",

volume = "28",

pages = "723--738",

journal = "Anesthesiology Clinics",

issn = "1932-2275",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Cardiovascular pharmacology

T2 - An update

AU - Liu, Henry

AU - Fox, Charles J.

AU - Zhang, Shihai

AU - Kaye, Alan D.

PY - 2010/12

Y1 - 2010/12

N2 - Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Some of these newer drugs are frequently used in the practice of cardiovascular anesthesiology. This article reviews the recent advances in cardiovascular medications related to the practice of cardiac anesthesia.

AB - Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Some of these newer drugs are frequently used in the practice of cardiovascular anesthesiology. This article reviews the recent advances in cardiovascular medications related to the practice of cardiac anesthesia.

UR - https://www.scopus.com/pages/publications/78149484990

UR - https://www.scopus.com/pages/publications/78149484990#tab=citedBy

U2 - 10.1016/j.anclin.2010.09.001

DO - 10.1016/j.anclin.2010.09.001

M3 - Review article

C2 - 21074748

AN - SCOPUS:78149484990

SN - 1932-2275

VL - 28

SP - 723

EP - 738

JO - Anesthesiology Clinics

JF - Anesthesiology Clinics

IS - 4

ER -

Cardiovascular pharmacology: An update

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this